Dupont Capital Management Corp boosted its position in CVS Health Corp (NYSE:CVS) by 1.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 321,460 shares of the pharmacy operator’s stock after acquiring an additional 3,043 shares during the quarter. CVS Health accounts for about 0.6% of Dupont Capital Management Corp’s holdings, making the stock its 23rd biggest holding. Dupont Capital Management Corp’s holdings in CVS Health were worth $26,141,000 at the end of the most recent reporting period.
A number of other large investors have also recently modified their holdings of CVS. FMR LLC raised its holdings in CVS Health by 22.0% in the second quarter. FMR LLC now owns 30,150,634 shares of the pharmacy operator’s stock valued at $2,425,920,000 after acquiring an additional 5,446,930 shares in the last quarter. Boston Partners raised its holdings in CVS Health by 69.1% in the second quarter. Boston Partners now owns 6,459,237 shares of the pharmacy operator’s stock valued at $519,711,000 after acquiring an additional 2,638,888 shares in the last quarter. Parametric Portfolio Associates LLC raised its holdings in CVS Health by 71.5% in the second quarter. Parametric Portfolio Associates LLC now owns 3,949,854 shares of the pharmacy operator’s stock valued at $317,805,000 after acquiring an additional 1,647,168 shares in the last quarter. Prudential Financial Inc. raised its holdings in CVS Health by 61.8% in the second quarter. Prudential Financial Inc. now owns 2,946,531 shares of the pharmacy operator’s stock valued at $237,078,000 after acquiring an additional 1,125,400 shares in the last quarter. Finally, Nordea Investment Management AB raised its holdings in CVS Health by 8.4% in the second quarter. Nordea Investment Management AB now owns 14,154,922 shares of the pharmacy operator’s stock valued at $1,138,905,000 after acquiring an additional 1,100,373 shares in the last quarter. 81.63% of the stock is currently owned by hedge funds and other institutional investors.
Several analysts recently weighed in on the stock. UBS Group raised shares of CVS Health from an “outperform” rating to a “strong-buy” rating in a report on Thursday. Raymond James Financial raised shares of CVS Health from an “outperform” rating to a “strong-buy” rating and set a $90.00 price objective on the stock in a report on Thursday. They noted that the move was a valuation call. Vetr cut shares of CVS Health from a “buy” rating to a “hold” rating and set a $77.11 price objective on the stock. in a report on Thursday. Royal Bank of Canada began coverage on shares of CVS Health in a report on Tuesday, September 19th. They set an “outperform” rating and a $95.00 price objective on the stock. Finally, Jefferies Group raised their price objective on shares of CVS Health from $82.00 to $86.00 and gave the stock a “hold” rating in a report on Friday, September 15th. One research analyst has rated the stock with a sell rating, nine have given a hold rating, eleven have issued a buy rating and two have issued a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $86.09.
CVS Health Corp (NYSE:CVS) opened at $75.13 on Friday. The company has a market cap of $76,110.00, a price-to-earnings ratio of 15.52, a PEG ratio of 1.29 and a beta of 0.90. CVS Health Corp has a 1-year low of $66.45 and a 1-year high of $84.72. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.05 and a quick ratio of 0.55.
CVS Health (NYSE:CVS) last announced its earnings results on Monday, November 6th. The pharmacy operator reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.49 by $0.01. The business had revenue of $46.18 billion for the quarter, compared to analysts’ expectations of $46.17 billion. CVS Health had a net margin of 2.77% and a return on equity of 16.96%. The company’s quarterly revenue was up 3.5% on a year-over-year basis. During the same period in the previous year, the company posted $1.64 EPS. analysts predict that CVS Health Corp will post 5.9 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 2nd. Stockholders of record on Wednesday, January 24th will be issued a $0.50 dividend. The ex-dividend date is Tuesday, January 23rd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.66%. CVS Health’s payout ratio is 41.32%.
TRADEMARK VIOLATION WARNING: This piece was originally reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this piece on another site, it was illegally stolen and republished in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.chaffeybreeze.com/2018/01/05/dupont-capital-management-corp-has-26-14-million-position-in-cvs-health-corp-cvs.html.
About CVS Health
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.